{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:46:49Z","timestamp":1792511209172,"version":"4.5.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T00:00:00Z","timestamp":1740182400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019779","name":"Qatar National Library","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019779","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009827","name":"Alexandria University","doi-asserted-by":"publisher","award":["CALL -1"],"award-info":[{"award-number":["CALL -1"]}],"id":[{"id":"10.13039\/501100009827","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.ejmech.2025.117415","type":"journal-article","created":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T19:54:27Z","timestamp":1740167667000},"page":"117415","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Novel thiazolones for the simultaneous modulation of PPAR\u03b3, COX-2 and 15-LOX to address metabolic disease-associated portal inflammation"],"prefix":"10.1016","volume":"289","author":[{"given":"Mai S.","family":"El-Shoukrofy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azza","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reem H.","family":"Elhamammy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherien A.","family":"Abdelhady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasha","family":"Nassra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica S.","family":"Makkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud A.","family":"Agami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Wahid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisham A.","family":"Nematalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minh","family":"Sai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Merk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed F.","family":"El-Yazbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed S.F.","family":"Belal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3004-5675","authenticated-orcid":false,"given":"Ali H.","family":"Eid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perihan A.","family":"Elzahhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.117415_bib1","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3390\/livers3040040","article-title":"Therapeutics for metabolic dysfunction-associated fatty liver disease (MAFLD)","volume":"3","author":"Bhopale","year":"2023","journal-title":"Livers"},{"key":"10.1016\/j.ejmech.2025.117415_bib2","first-page":"42","article-title":"MAFLD: exploring the systemic effects beyond liver","volume":"15","author":"Dayal","year":"2025","journal-title":"J. Community Hosp. Intern. Med. Perspect."},{"key":"10.1016\/j.ejmech.2025.117415_bib3","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s13105-023-00954-4","article-title":"Metabolic dysfunction\u2013associated fatty liver disease (MAFLD): an update of the recent advances in pharmacological treatment","volume":"79","author":"Sangro","year":"2023","journal-title":"J. Physiol. Biochem."},{"key":"10.1016\/j.ejmech.2025.117415_bib4","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1136\/jcp.2010.079145","article-title":"Portal inflammation is associated with advanced histological changes in alcoholic and non-alcoholic fatty liver disease","volume":"63","author":"Rakha","year":"2010","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.ejmech.2025.117415_bib5","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S2213-8587(14)70032-4","article-title":"Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome","volume":"2","author":"Yki-J\u00e4rvinen","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.ejmech.2025.117415_bib6","first-page":"252","article-title":"ETIOLOGY of hepatocellular carcinoma, special FOCUS ON fatty liver disease, insights","volume":"3","author":"Tanveer","year":"2025","journal-title":"J.Health Rehabilitat."},{"key":"10.1016\/j.ejmech.2025.117415_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers13040730","article-title":"Inflammatory mechanisms underlying nonalcoholic steatohepatitis and the transition to hepatocellular carcinoma","volume":"13","author":"Peiseler","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.ejmech.2025.117415_bib8","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1002\/hep.26937","article-title":"The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease","volume":"59","author":"Gadd","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.ejmech.2025.117415_bib9","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s40265-024-02045-0","article-title":"Resmetirom: first approval","volume":"84","author":"Keam","year":"2024","journal-title":"Drugs"},{"key":"10.1016\/j.ejmech.2025.117415_bib10","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1021\/acs.jmedchem.1c02002","article-title":"Design, synthesis, and biological evaluation of triazolone derivatives as potent ppar\u03b1\/\u03b4Dual agonists for the treatment of nonalcoholic steatohepatitis","volume":"65","author":"Feng","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117415_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26010306","article-title":"NAFLD and NAFLD related HCC: emerging treatments and clinical trials","volume":"26","author":"Khare","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.117415_bib12","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.2147\/DDDT.S315724","article-title":"Non-alcoholic steatohepatitis (NASH) - a review of a crowded clinical landscape, driven by a complex disease","volume":"15","author":"Fraile","year":"2021","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ejmech.2025.117415_bib13","article-title":"Identification of novel organo-Se BTSA-based derivatives as potent, reversible, and selective PPAR\u03b3 covalent modulators for antidiabetic drug discovery","author":"Chen","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117415_bib14","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.2337\/dc19-0167","article-title":"Role of vitamin E for nonalcoholic steatohepatitis in patients with type 2 diabetes: a randomized controlled trial","volume":"42","author":"Bril","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejmech.2025.117415_bib15","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.chembiol.2021.04.019","article-title":"Endogenous vitamin E metabolites mediate allosteric PPAR\u03b3 activation with unprecedented co-regulatory interactions","volume":"28","author":"Willems","year":"2021","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.ejmech.2025.117415_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/mmr.2021.12463","article-title":"Ppar\u03b3 attenuates hepatic inflammation and oxidative stress of non-alcoholic steatohepatitis via modulating the mir-21-5p\/sfrp5 pathway","volume":"24","author":"Zhang","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ejmech.2025.117415_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113127","article-title":"Natural PPARs agonists for the treatment of nonalcoholic fatty liver disease","volume":"151","author":"Pan","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2025.117415_bib18","first-page":"811","article-title":"Celecoxib attenuates liver steatosis and inflammation in non-alcoholic steatohepatitis induced by high-fat diet in rats","volume":"4","author":"Chen","year":"2011","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ejmech.2025.117415_bib19","article-title":"Celecoxib ameliorates non-alcoholic steatohepatitis in type 2 diabetic rats via suppression of the non-canonical Wnt signaling pathway expression","volume":"9","author":"Tian","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2025.117415_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e09872","article-title":"Celecoxib-mediated attenuation of non-alcoholic steatohepatitis is potentially relevant to redistributing the expression of adiponectin receptors in rats","volume":"8","author":"Zhu","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.ejmech.2025.117415_bib21","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1002\/hep.23229","article-title":"The plasma lipidomic signature of nonalcoholic steatohepatitis","volume":"50","author":"Puri","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.ejmech.2025.117415_bib22","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.ejmech.2019.02.034","article-title":"Shooting three inflammatory targets with a single bullet: novel multi-targeting anti-inflammatory glitazones","volume":"167","author":"Elzahhar","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117415_bib23","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1080\/14756366.2021.1887169","article-title":"Challenging inflammatory process at molecular, cellular and in vivo levels via some new pyrazolyl thiazolones","volume":"36","author":"Elzahhar","year":"2021","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117415_bib24","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.trsl.2019.07.009","article-title":"Amelioration of perivascular adipose inflammation reverses vascular dysfunction in a model of nonobese prediabetic metabolic challenge: potential role of antidiabetic drugs","volume":"214","author":"Elkhatib","year":"2019","journal-title":"Transl. Res."},{"key":"10.1016\/j.ejmech.2025.117415_bib25","doi-asserted-by":"crossref","first-page":"E835","DOI":"10.1152\/ajpendo.00145.2020","article-title":"Worsening baroreflex sensitivity on progression to type 2 diabetes: localized vs. systemic inflammation and role of antidiabetic therapy","volume":"319","author":"Bakkar","year":"2020","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ejmech.2025.117415_bib26","doi-asserted-by":"crossref","first-page":"4027","DOI":"10.1021\/jm101360s","article-title":"Targeting peroxisome proliferator-activated receptors (PPARs): development of modulators","volume":"55","author":"Pirat","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117415_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108391","article-title":"PPAR-\u03b3 signaling in nonalcoholic fatty liver disease: pathogenesis and therapeutic targets","volume":"245","author":"Chen","year":"2023","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2025.117415_bib28","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/jcp.24443","article-title":"15-LO\/15-HETE mediated vascular adventitia fibrosis via p38 MAPK-dependent TGF-\u03b2","volume":"229","author":"Zhang","year":"2014","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ejmech.2025.117415_bib29","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1210\/en.2006-0665","article-title":"The role of 12\/15-lipoxygenase in the expression of interleukin-6 and tumor necrosis factor-alpha in macrophages","volume":"148","author":"Wen","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejmech.2025.117415_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2024.103276","article-title":"Protocol for producing a rat model of non-obese prediabetes using a mild hypercaloric diet approach","volume":"5","author":"Dwaib","year":"2024","journal-title":"STAR Protoc"},{"key":"10.1016\/j.ejmech.2025.117415_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114491","article-title":"Peri-renal adipose inflammation contributes to renal dysfunction in a non-obese prediabetic rat model: role of anti-diabetic drugs","volume":"186","author":"Hammoud","year":"2021","journal-title":"Biochem. Pharmacol."},{"issue":"1 7","key":"10.1016\/j.ejmech.2025.117415_bib32","first-page":"1","article-title":"Novel benzylidene thiazolidinedione derivatives as partial PPAR\u03b3 agonists and their antidiabetic effects on type 2 diabetes","volume":"7","author":"Yasmin","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2025.117415_bib33","doi-asserted-by":"crossref","first-page":"W513","DOI":"10.1093\/nar\/gkae303","article-title":"ProTox 3.0: a webserver for the prediction of toxicity of chemicals","volume":"52","author":"Banerjee","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2025.117415_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.5427","article-title":"In\u2010depth investigation of the Silymarin effect on the pharmacokinetic parameters of sofosbuvir, GS\u2010331007 and ledipasvir in rat plasma using LC\u2013MS","volume":"36","author":"Aboras","year":"2022","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.ejmech.2025.117415_bib35","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/bdd.2510080106","article-title":"Method of residuals: estimation of absorption and elimination rate constants having comparable values","volume":"8","author":"Macheras","year":"1987","journal-title":"Biopharm Drug Dispos."},{"key":"10.1016\/j.ejmech.2025.117415_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120956","article-title":"Metformin, pioglitazone, dapagliflozin and their combinations ameliorate manifestations associated with NAFLD in rats via anti-inflammatory, anti-fibrotic, anti-oxidant and anti-apoptotic mechanisms","volume":"308","author":"Shaaban","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2025.117415_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/816856","article-title":"Review of the structural and dynamic mechanisms of PPAR \u03b3 partial agonism","volume":"2015","author":"Kroker","year":"2015","journal-title":"PPAR Res."},{"key":"10.1016\/j.ejmech.2025.117415_bib38","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jafc.4c05234","article-title":"Discovery of new 1,2,4-triazole\/1,3,4-oxadiazole-decorated quinolinones as agrochemical alternatives for controlling viral infection by inhibiting the viral replication and self-assembly process","author":"Liao","year":"2024","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ejmech.2025.117415_bib39","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.bmcl.2015.01.041","article-title":"Environmentally benign synthesis, molecular properties prediction and anti-inflammatory activity of novel isoxazolo[5,4-d]isoxazol-3-yl-aryl-methanones via vinylogous Henry nitroaldol adducts as synthons","volume":"25","author":"Rajanarendar","year":"2015","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2025.117415_bib40","doi-asserted-by":"crossref","first-page":"11035","DOI":"10.1021\/acs.jafc.3c02615","article-title":"Discovery and structural optimization of 1,2,3,4-Tetrahydro-\u03b2-carbolines as novel reactive oxygen species inducers for controlling intractable plant bacterial diseases","volume":"71","author":"Liu","year":"2023","journal-title":"J. Agric. Food Chem."},{"issue":"12 17","key":"10.1016\/j.ejmech.2025.117415_bib41","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1007\/s11705-023-2361-5","article-title":"Discovery of novel ursolic acid derivatives as effective antimicrobial agents through a ROS-mediated apoptosis mechanism","volume":"17","author":"Yang","year":"2023","journal-title":"Front. Chem. Sci. Eng."},{"key":"10.1016\/j.ejmech.2025.117415_bib42","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117415_bib43","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.1016\/j.bmcl.2013.04.086","article-title":"The development of CNS-active LRRK2 inhibitors using property-directed optimisation","volume":"23","author":"Kavanagh","year":"2013","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2025.117415_bib44","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1517\/17460441.2.4.469","article-title":"Ligand efficiency indices for effective drug discovery","volume":"2","author":"Abad-Zapatero","year":"2007","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2025.117415_bib45","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S1359-6446(04)03069-7","article-title":"Ligand efficiency: a useful metric for lead selection","volume":"9","author":"Hopkins","year":"2004","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2025.117415_bib46","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nrd4163","article-title":"The role of ligand efficiency metrics in drug discovery","volume":"13","author":"Hopkins","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2025.117415_bib47","first-page":"130","article-title":"Synthesis and biological evaluation of novel thiosemicarbazone \u2013 triazole hybrid compounds antimalarial agents","volume":"66","author":"Kinfe","year":"2013","journal-title":"S. Afr. J. Chem."},{"key":"10.1016\/j.ejmech.2025.117415_bib48","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ejmech.2016.03.041","article-title":"Anti-methicillin resistant Staphylococcus aureus activity, synergism with oxacillin and molecular docking studies of metronidazole-triazole hybrids","volume":"115","author":"Negi","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117415_bib49","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.3390\/molecules21091230","article-title":"Combinatorial synthesis of structurally diverse triazole-bridged flavonoid dimers and trimers","volume":"21","author":"Sum","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117415_bib50","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.ejmech.2018.04.003","article-title":"Anti-leishmanial click modifiable thiosemicarbazones: design, synthesis, biological evaluation and in silico studies","volume":"151","author":"Temraz","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117415_bib51","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.ejmech.2016.09.009","article-title":"Synthesis and apoptosis inducing studies of triazole linked 3-benzylidene isatin derivatives","volume":"124","author":"Nagarsenkar","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117415_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112439","article-title":"Expanding the anticancer potential of 1,2,3-triazoles via simultaneously targeting Cyclooxygenase-2, 15-lipoxygenase and tumor-associated carbonic anhydrases","volume":"200","author":"Elzahhar","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117415_bib53","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.ejmech.2010.12.019","article-title":"Synthesis, glucose uptake activity and structure-activity relationships of some novel glitazones incorporated with glycine, aromatic and alicyclic amine moieties via two carbon acyl linker","volume":"46","author":"Kumar","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117415_bib54","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.bioorg.2014.05.006","article-title":"Design, synthesis and glucose uptake activity of some novel glitazones","volume":"56","author":"Kar","year":"2014","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117415_bib55","doi-asserted-by":"crossref","first-page":"W609","DOI":"10.1093\/nar\/gkq300","article-title":"PharmMapper server: a web server for potential drug target identification using pharmacophore mapping approach","volume":"38","author":"Liu","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2025.117415_bib56","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s10593-014-1496-1","article-title":"Prediction of the biological activity spectra of organic compounds using the pass online web resource","volume":"50","author":"Filimonov","year":"2014","journal-title":"Chem. Heterocycl. Compd."},{"key":"10.1016\/j.ejmech.2025.117415_bib57","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1093\/bioinformatics\/btz931","article-title":"ShinyGO: a graphical gene-set enrichment tool for animals and plants","volume":"36","author":"Ge","year":"2020","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ejmech.2025.117415_bib58","doi-asserted-by":"crossref","first-page":"14802","DOI":"10.1021\/jacs.3c03417","article-title":"Targeting the alternative vitamin E metabolite binding site enables noncanonical PPAR\u03b3 modulation","volume":"145","author":"Arifi","year":"2023","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2025.117415_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116138","article-title":"Chromone-based small molecules for multistep shutdown of arachidonate pathway: simultaneous inhibition of COX-2, 15-LOX and mPGES-1 enzymes","volume":"266","author":"Elzahhar","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117415_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13765-020-00504-2","article-title":"Anti-inflammatory effect of hispidin on LPS induced macrophage inflammation through MAPK and JAK1\/STAT3 signaling pathways","volume":"63","author":"Han","year":"2020","journal-title":"Appl Biol Chem"},{"key":"10.1016\/j.ejmech.2025.117415_bib61","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bioorg.2017.05.007","article-title":"Synthesis, molecular docking and anti-diabetic evaluation of 2,4-thiazolidinedione based amide derivatives","volume":"73","author":"Naim","year":"2017","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117415_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115333","article-title":"Modulating leishmanial pteridine metabolism machinery via some new coumarin-1,2,3-triazoles: design, synthesis and computational studies","volume":"253","author":"Hassan","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"1 7","key":"10.1016\/j.ejmech.2025.117415_bib63","first-page":"1","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425001801?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425001801?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T23:07:32Z","timestamp":1778540852000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425001801"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":63,"alternative-id":["S0223523425001801"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117415","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel thiazolones for the simultaneous modulation of PPAR\u03b3, COX-2 and 15-LOX to address metabolic disease-associated portal inflammation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117415","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117415"}}